From: HPV infection and endometrial polyps: insights from a case-control study
 | Cases No.(%) | Controls No.(%) | Adjusted OR | CI (95%) |
---|---|---|---|---|
Age | Â | Â | Â | Â |
<30 | 6(19.4%) | 7 (22.6%) | 1 | Â |
≥30 | 25 (80.6%) | 24 (77.4%) | 1.12 | (0.29 – 4.28) |
BMI | Â | Â | Â | Â |
<30 | 27 (87.1%) | 25 (80.6%) | 1 | Â |
≥30 | 4 (12.9%) | 6 (19.4%) | 0.8 | (0.1 – 3.5) |
EL | Â | Â | Â | Â |
>12 | 18 (58.1%) | 27 (87.1%) | 1 | Â |
≤12 | 13 (41.9%) | 4 (12.9%) | 5.8 | (1.57 – 21.6) |
HPV | Â | Â | Â | Â |
Negative | 27 (87.1%) | 30 (96.8%) | 1 | Â |
Positive | 4 (12.9%) | 1 (3.2%) | 7.4 | (0.7 – 73.6) |